The European Medicines Agency (EMA) has cut the UK Medicines and Healthcare Products Regulatory...
- The People vs Big Pharma: tackling the industry’s trust issues
- AbbVie poised to overtake Gilead as hepatitis C leader
- The influence of coagulation cascade targets in CVD
- UK bioethics panel finds human genome editing ethically acceptable
- 15% of drug compounding facilities have violated FDA regulations
Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals
Production of hormone medication involves packing in foil blister packs. The process includes cooling and requires very cold machine surfaces.
Detecting Integrity Breaches in Pharmaceutical Blister Packaging
Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents.
Brexit backlash: EU cuts UK’s MHRA out of drug approval process
The European Medicines Agency (EMA) has cut the UK Medicines and Healthcare Products Regulatory Agency (MHRA) out of its drug approval process seven months earlier than expected in preparation for Brexit, according to media reports. The move will slash the MHRA’s annual budget by approximately €50m ($59M).
Roche’s Rituxan biosimilar woes are just beginning
Last week, Roche filed a Worker Adjustment and Retraining Notification to the State of California’s Employment Development Department, citing plans to lay off 223 employees at its Genentech site.
Blockbuster asthma drug Xolair gains breakthrough status for food allergies
This approval has come on the back of several clinical trials that have shown that Xolair was effective at relieving several commonly found food allergies, including allergies to peanuts, milk and eggs.
Regulatory Consulting and Labelling Translation Services
Within the marketing authorisation application (MAA) process of a medicinal product in the EU, the product labelling is a core element of the information describing the medicinal product.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.